FDA Approved: VORICONAZOLE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Voriconazole from Sandoz Inc, approving a generic version of the antifungal medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Aspergillosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

SUPPL AP for VORICONAZOLE (VORICONAZOLE)